Clinical evaluation of the bispecific antibody MDX-H210 (anti FcRI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (Filgramostim) for treatment of advanced breast cancer

H.H. van Ojik, R. Repp, G. Groenewegen, T. Valerius, J.G.J. van de Winkel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)207-209
Number of pages3
JournalCancer Immunology, Immunotherapy
Volume45
Publication statusPublished - 1997

Bibliographical note

keypublication

Cite this